Nektar Therapeutics (NKTR) Declined -5.96% or -2.26 To Price $35.69 On Thursday

Nektar Therapeutics (NKTR) declined -5.96% or -2.26 to $35.69. It is about 2.32 million shares traded, which is 95.73% compare to the average total volume 2.43 million. The market cap of NKTR is $6.16 billion. The year to date change is -40.13%. The 52 week price range is from $28.27 to $111.36. Price of NKTR have changed -6.73% during last week. It have changed -26.68% over last month, -30.52% over last 3 months, -51.82% over last 6 months and 41.39% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NKTR is 52.78. It is 47.88% above current price. The 200-day Moving Averages for NKTR is 69.78. It is 95.52% above current price. The 52-week High is 111.36. It is 212.02% from the current price. The 52-week Low is 28.27. It is -20.79% from current price.

There are some statistics of NKTR. It is has market cap $6.16 billion. The share outstanding is 172.47 million. The average volume is 2.43 million. The revenue is 152.93M. It has 352.57M cash and 247.25M in debt. The gross profit is 147.25M. The percent of top 15 Institution holding is 174.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NKTR is 96.87%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NKTR is 64.74%.


Share this post